Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hand-Foot Syndrome × Celecoxib × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 29 Colonic Neoplasms 15 Rectal Neoplasms 12 Pancreatic Neoplasms 7 Esophageal Neoplasms 7 Adenomatous Polyposis Coli 7 Neoplasm Metastasis 3 Liver Neoplasms 3 Carcinoma, Hepatocellular 3 Thymoma 2 Lung Neoplasms 2 Locally Advanced Rectal Cancer 2 Gastrointestinal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Adenocarcinoma Of Esophagus 2 Turcot syndrome 1 Thrombocytosis 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Polyps 1 Pancreatic Cancer Metastatic 1 Pain, Postoperative 1 Neoplastic Syndromes, Hereditary 1 Neoplasms 1 Myeloproliferative Disorders 1

Interventions

tegafur-gimeracil-oteracil 1 S 1 (combination) 1 Pharmacokinetics 1 Celecoxib 1 Capecitabine 1 Blood Specimen Collection 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05327751 2022-04-14

HFS

Tanta University

Phase 3 Unknown

Gastrointestinal

Colorectal Neoplasms, Hand-Foot Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡